190 related articles for article (PubMed ID: 23358504)
21. Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development.
Shin J; Padmanabhan A; de Groh ED; Lee JS; Haidar S; Dahlberg S; Guo F; He S; Wolman MA; Granato M; Lawson ND; Wolfe SA; Kim SH; Solnica-Krezel L; Kanki JP; Ligon KL; Epstein JA; Look AT
Dis Model Mech; 2012 Nov; 5(6):881-94. PubMed ID: 22773753
[TBL] [Abstract][Full Text] [Related]
22. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
[TBL] [Abstract][Full Text] [Related]
23. RAS/MEK-independent gene expression reveals BMP2-related malignant phenotypes in the Nf1-deficient MPNST.
Sun D; Haddad R; Kraniak JM; Horne SD; Tainsky MA
Mol Cancer Res; 2013 Jun; 11(6):616-27. PubMed ID: 23423222
[TBL] [Abstract][Full Text] [Related]
24. Alternative splicing of the neurofibromatosis type I pre-mRNA.
Barron VA; Lou H
Biosci Rep; 2012 Apr; 32(2):131-8. PubMed ID: 22115364
[TBL] [Abstract][Full Text] [Related]
25. The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway.
Ozawa T; Araki N; Yunoue S; Tokuo H; Feng L; Patrakitkomjorn S; Hara T; Ichikawa Y; Matsumoto K; Fujii K; Saya H
J Biol Chem; 2005 Nov; 280(47):39524-33. PubMed ID: 16169856
[TBL] [Abstract][Full Text] [Related]
26. Growth factor regulation of cytoplasmic dynein intermediate chain subunit expression preceding neurite extension.
Salata MW; Dillman JF; Lye RJ; Pfister KK
J Neurosci Res; 2001 Sep; 65(5):408-16. PubMed ID: 11536324
[TBL] [Abstract][Full Text] [Related]
27. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
28. Neurofibromatosis type 1 alternative splicing is a key regulator of Ras/ERK signaling and learning behaviors in mice.
Nguyen HT; Hinman MN; Guo X; Sharma A; Arakawa H; Luo G; Lou H
Hum Mol Genet; 2017 Oct; 26(19):3797-3807. PubMed ID: 28934393
[TBL] [Abstract][Full Text] [Related]
29. Multi-Omics Profiling for NF1 Target Discovery in Neurofibromin (NF1) Deficient Cells.
Carnes RM; Mobley JA; Crossman DK; Liu H; Korf BR; Kesterson RA; Wallis D
Proteomics; 2019 Jun; 19(11):e1800334. PubMed ID: 30908848
[TBL] [Abstract][Full Text] [Related]
30. Neurofibromatosis 1: closing the GAP between mice and men.
Dasgupta B; Gutmann DH
Curr Opin Genet Dev; 2003 Feb; 13(1):20-7. PubMed ID: 12573431
[TBL] [Abstract][Full Text] [Related]
31. Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma.
Lau N; Feldkamp MM; Roncari L; Loehr AH; Shannon P; Gutmann DH; Guha A
J Neuropathol Exp Neurol; 2000 Sep; 59(9):759-67. PubMed ID: 11005256
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of a high-content screening assay to identify inhibitors of cytoplasmic dynein-mediated transport of glucocorticoid receptor to the nucleus.
Johnston PA; Shinde SN; Hua Y; Shun TY; Lazo JS; Day BW
Assay Drug Dev Technol; 2012 Oct; 10(5):432-56. PubMed ID: 22830992
[TBL] [Abstract][Full Text] [Related]
33. Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis.
Hegedus B; Yeh TH; Lee DY; Emnett RJ; Li J; Gutmann DH
Hum Mol Genet; 2008 Oct; 17(19):2956-66. PubMed ID: 18614544
[TBL] [Abstract][Full Text] [Related]
34. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.
Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH
Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007
[TBL] [Abstract][Full Text] [Related]
35. Physical interaction between neurofibromin and serotonin 5-HT6 receptor promotes receptor constitutive activity.
Deraredj Nadim W; Chaumont-Dubel S; Madouri F; Cobret L; De Tauzia ML; Zajdel P; Bénédetti H; Marin P; Morisset-Lopez S
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12310-12315. PubMed ID: 27791021
[TBL] [Abstract][Full Text] [Related]
36. The neurofibromatosis type 1 tumor suppressor controls cell growth by regulating signal transducer and activator of transcription-3 activity in vitro and in vivo.
Banerjee S; Byrd JN; Gianino SM; Harpstrite SE; Rodriguez FJ; Tuskan RG; Reilly KM; Piwnica-Worms DR; Gutmann DH
Cancer Res; 2010 Feb; 70(4):1356-66. PubMed ID: 20124472
[TBL] [Abstract][Full Text] [Related]
37. Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells.
McDaniel AS; Allen JD; Park SJ; Jaffer ZM; Michels EG; Burgin SJ; Chen S; Bessler WK; Hofmann C; Ingram DA; Chernoff J; Clapp DW
Blood; 2008 Dec; 112(12):4646-54. PubMed ID: 18768391
[TBL] [Abstract][Full Text] [Related]
38. Neurofibromin-deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration-implications for increased neurofibroma formation during pregnancy.
Nebesio TD; Ming W; Chen S; Clegg T; Yuan J; Yang Y; Estwick SA; Li Y; Li X; Hingtgen CM; Yang FC
Glia; 2007 Apr; 55(5):527-36. PubMed ID: 17236191
[TBL] [Abstract][Full Text] [Related]
39. The oncogenic role of NF1 in gallbladder cancer through regulation of YAP1 stability by direct interaction with YAP1.
Zhang L; Jiang L; Zeng L; Jin Z; Dong X; Zhang Y; Chen L; Shu Y; Liu Y; Huang Y
J Transl Med; 2023 May; 21(1):306. PubMed ID: 37147639
[TBL] [Abstract][Full Text] [Related]
40. Isoform-specific NF1 mRNA levels correlate with disease severity in Neurofibromatosis type 1.
Assunto A; Ferrara U; De Luca A; Pivonello C; Lombardo L; Piscitelli A; Tortora C; Pinna V; Daniele P; Pivonello R; Russo MG; Limongelli G; Colao A; Tartaglia M; Strisciuglio P; Melis D
Orphanet J Rare Dis; 2019 Nov; 14(1):261. PubMed ID: 31730495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
